Chang JC - Search Results

1

Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.

Liu ZB, Ezzedine NE, Eterovic AK, Ensor JE, Huang HJ, Albanell J, Choi DS, Lluch A, Liu Y, Rojo F, Wong H, Martínez-Dueñas E, Guerrero-Zotano Á, Shao ZM, Darcourt JG, Mills GB, Dave B, Chang JC. Liu ZB, et al. Among authors: chang jc. Breast Cancer Res Treat. 2019 Nov;178(2):251-261. doi: 10.1007/s10549-019-05374-x. Epub 2019 Aug 6. Breast Cancer Res Treat. 2019. PMID: 31388936 Free PMC article.

2

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

Chang J, Hilsenbeck SG, Sng JH, Wong J, Ragu GC. Chang J, et al. Clin Cancer Res. 2001 Jun;7(6):1739-42. Clin Cancer Res. 2001. PMID: 11410514

3

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM. Chang J, et al. Breast Cancer Res Treat. 2001 Sep;69(2):101-13. doi: 10.1023/a:1012203917104. Breast Cancer Res Treat. 2001. PMID: 11759816 Review.

4

Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer.

Tham YL, Verani MS, Chang J. Tham YL, et al. Breast Cancer Res Treat. 2002 Jul;74(2):131-4. doi: 10.1023/a:1016140729725. Breast Cancer Res Treat. 2002. PMID: 12186373

5

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Chang J, et al. Cancer. 2003 Feb 1;97(3):545-53. doi: 10.1002/cncr.11083. Cancer. 2003. PMID: 12548595 Free article.

6

Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results.

Van Pelt AE, Mohsin S, Elledge RM, Hilsenbeck SG, Gutierrez MC, Lucci A Jr, Kalidas M, Granchi T, Scott BG, Allred DC, Chang JC. Van Pelt AE, et al. Among authors: chang jc. Clin Breast Cancer. 2003 Dec;4(5):348-53. doi: 10.3816/cbc.2003.n.040. Clin Breast Cancer. 2003. PMID: 14715110

7

Genomic approaches in the management and treatment of breast cancer.

Chang JC, Hilsenbeck SG, Fuqua SA. Chang JC, et al. Br J Cancer. 2005 Feb 28;92(4):618-24. doi: 10.1038/sj.bjc.6602410. Br J Cancer. 2005. PMID: 15714204 Free PMC article. Review.

8

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Tham YL, Kalidas M, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, Lewis MT, Wong H, O'Connell P. Chang JC, et al. J Clin Oncol. 2005 Feb 20;23(6):1169-77. doi: 10.1200/JCO.2005.03.156. J Clin Oncol. 2005. PMID: 15718313

9

The promise of microarrays in the management and treatment of breast cancer.

Chang JC, Hilsenbeck SG, Fuqua SA. Chang JC, et al. Breast Cancer Res. 2005;7(3):100-4. doi: 10.1186/bcr1018. Epub 2005 Apr 1. Breast Cancer Res. 2005. PMID: 15987438 Free PMC article. Review.

10

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers.

Tham YL, Gomez LF, Mohsin S, Gutierrez MC, Weiss H, Hilsenbeck SG, Elledge RM, Chamness GC, Osborne CK, Allred DC, Chang JC. Tham YL, et al. Among authors: chang jc. Breast Cancer Res Treat. 2005 Dec;94(3):279-84. doi: 10.1007/s10549-005-9020-z. Breast Cancer Res Treat. 2005. PMID: 16261403 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,300 results

Search Page

Filters